Header Logo

Connection

LARRY LIPSHULTZ to Prostatic Neoplasms

Back to Details
This is a "connection" page, showing publications LARRY LIPSHULTZ has written about Prostatic Neoplasms.
LARRY LIPSHULTZ
Connection Strength
1.931
Prostatic Neoplasms
  1. Words of Wisdom. Re: incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries. Eur Urol. 2015 Jun; 67(6):1186-7.
    View in: PubMed
    Score: 0.257
  2. Words of wisdom. Re: Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study. Eur Urol. 2014 Dec; 66(6):1186-7.
    View in: PubMed
    Score: 0.248
  3. Testosterone therapy and cancer risk. BJU Int. 2015 Feb; 115(2):317-21.
    View in: PubMed
    Score: 0.246
  4. Words of wisdom. Re: Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the radiation therapy oncology group [0831] randomized clinical trial. Eur Urol. 2014 Sep; 66(3):594-5.
    View in: PubMed
    Score: 0.244
  5. The safety of testosterone supplementation therapy in prostate cancer. Nat Rev Urol. 2014 Sep; 11(9):526-30.
    View in: PubMed
    Score: 0.242
  6. Testosterone replacement therapy in men on active surveillance for prostate cancer. J Sex Med. 2025 Apr 08; 22(3):432-438.
    View in: PubMed
    Score: 0.127
  7. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sex Med Rev. 2019 01; 7(1):84-94.
    View in: PubMed
    Score: 0.082
  8. The Effect of Shift Work on Urogenital Disease: a Systematic Review. Curr Urol Rep. 2018 May 28; 19(8):57.
    View in: PubMed
    Score: 0.079
  9. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194(5):1271-6.
    View in: PubMed
    Score: 0.064
  10. Current state of practice regarding testosterone supplementation therapy in men with prostate cancer. Steroids. 2014 Nov; 89:27-32.
    View in: PubMed
    Score: 0.061
  11. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44.
    View in: PubMed
    Score: 0.055
  12. Testosterone replacement therapy in the setting of prostate cancer treated with radiation. Int J Impot Res. 2013 Jan; 25(1):24-8.
    View in: PubMed
    Score: 0.053
  13. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011 Apr; 185(4):1256-60.
    View in: PubMed
    Score: 0.048
  14. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr; 6(4):1165-1170.
    View in: PubMed
    Score: 0.041
  15. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am. 2007 Nov; 34(4):549-53, vi.
    View in: PubMed
    Score: 0.038
  16. Significance of the polyglutamine tract polymorphism in the androgen receptor. Urology. 2001 Nov; 58(5):651-6.
    View in: PubMed
    Score: 0.025
  17. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med. 2010 Nov; 7(11):3659-65.
    View in: PubMed
    Score: 0.012
  18. The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. Int J Impot Res. 2010 Jan-Feb; 22(1):20-4.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.